Header cover image

Danish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedMay 23, 2025
DataAggregated Company Financials
Companies2
  • 7D1.4%
  • 3M-26.3%
  • 1Y31.4%
  • YTDn/a

All of the companies in the Clinical Research and Equipment industry have been up over the last week, with the industry up 3.8%. This takes the industry's 12 month performance to a gain of 39%. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Danish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 23 May 2025DKK 15.3bDKK 725.3mDKK 132.6m52.7x115.4x21.1x
Sun, 20 Apr 2025DKK 14.1bDKK 725.3mDKK 132.6m49.3x106.7x19.5x
Tue, 18 Mar 2025DKK 18.0bDKK 725.3mDKK 132.6m55.6x135.6x24.8x
Thu, 13 Feb 2025DKK 20.9bDKK 683.4mDKK 122.6m58.8x170.5x30.6x
Sat, 11 Jan 2025DKK 20.4bDKK 631.7mDKK 89.8m70.1x227.4x32.3x
Mon, 09 Dec 2024DKK 19.8bDKK 631.7mDKK 89.8m61.5x220.6x31.3x
Wed, 06 Nov 2024DKK 13.6bDKK 631.7mDKK 89.8m49.5x151x21.5x
Fri, 04 Oct 2024DKK 14.6bDKK 631.7mDKK 89.8m50.7x162.4x23.1x
Sun, 01 Sep 2024DKK 15.8bDKK 625.4mDKK 97.3m45.3x162.2x25.2x
Tue, 30 Jul 2024DKK 16.8bDKK 606.5mDKK 99.3m44.8x169.2x27.7x
Thu, 27 Jun 2024DKK 12.6bDKK 606.5mDKK 99.3m37x127x20.8x
Sat, 25 May 2024DKK 11.4bDKK 606.5mDKK 99.3m44.4x115.3x18.9x
Mon, 22 Apr 2024DKK 9.6bDKK 606.5mDKK 99.3m34.5x96.4x15.8x
Wed, 20 Mar 2024DKK 12.5bDKK 606.5mDKK 99.3m51.1x125.7x20.6x
Fri, 16 Feb 2024DKK 10.2bDKK 605.1mDKK 136.8m53.5x74.8x16.9x
Sun, 14 Jan 2024DKK 8.6bDKK 647.9mDKK 171.7m36.9x50.1x13.3x
Tue, 12 Dec 2023DKK 7.9bDKK 647.9mDKK 171.7m33.2x45.9x12.2x
Thu, 09 Nov 2023DKK 7.9bDKK 647.9mDKK 171.7m34.1x46.2x12.2x
Sat, 07 Oct 2023DKK 7.4bDKK 647.9mDKK 171.7m32.2x43.4x11.5x
Mon, 04 Sep 2023DKK 9.3bDKK 664.8mDKK 172.7m41.4x53.9x14x
Wed, 02 Aug 2023DKK 9.2bDKK 660.6mDKK 184.0m198.8x49.9x13.9x
Fri, 30 Jun 2023DKK 9.4bDKK 660.6mDKK 184.0m200.1x51.1x14.2x
Sun, 28 May 2023DKK 9.9bDKK 660.6mDKK 184.0m216.6x53.7x15x
Tue, 25 Apr 2023DKK 6.3bDKK 461.2mDKK 179.7m34.8x34.8x13.6x
Thu, 23 Mar 2023DKK 6.9bDKK 461.2mDKK 179.7m38.2x38.2x14.9x
Sat, 18 Feb 2023DKK 8.9bDKK 461.2mDKK 179.7m49.7x49.7x19.4x
Mon, 16 Jan 2023DKK 11.5bDKK 428.4mDKK 159.5m72.4x72.4x26.9x
Wed, 14 Dec 2022DKK 15.1bDKK 428.4mDKK 159.5m94.4x94.4x35.2x
Fri, 11 Nov 2022DKK 14.8bDKK 428.4mDKK 159.5m92.5x92.5x34.4x
Sun, 09 Oct 2022DKK 10.7bDKK 428.4mDKK 159.5m67.2x67.2x25x
Tue, 06 Sep 2022DKK 12.7bDKK 358.0mDKK 131.3m96.8x96.8x35.5x
Thu, 04 Aug 2022DKK 15.3bDKK 358.0mDKK 131.3m116.3x116.3x42.6x
Sat, 02 Jul 2022DKK 13.3bDKK 358.0mDKK 131.3m101.3x101.3x37.1x
Mon, 30 May 2022DKK 12.4bDKK 358.0mDKK 131.3m94.6x94.6x34.7x
Price to Earnings Ratio

94.6x


Total Market Cap: DKK 12.4bTotal Earnings: DKK 131.3mTotal Revenue: DKK 358.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Clinical Research and Equipment Industry Price to Earnings3Y Average 100.6x202320242025
Current Industry PE
    There are only 2 companies in the Danish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 27% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Danish Clinical Research and Equipment compare with similar industries?

DK Market1.85%
Healthcare2.68%
Life Sciences1.39%
Clinical Research and Equipment1.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CHEMM ChemoMetecDKK 512.502.8%
+DKK 241.9m
38.8%PE52.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.